Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...
October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-breaking ...
October 9, 2019 – Fujifilm Medical Systems U.S.A. Inc. recently launched Synapse Cardiology PACS 5.6.1, the company’s ...
October 9, 2019 — In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date ...
Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...
October 8, 2019 — Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of ...
American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...
October 7, 2019 – A recent study published in the New England Journal of Medicine supports the use of cardiac magnetic ...
Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...
October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...
October 3, 2019 – Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
October 10, 2019